Extract of Cassiae Semen and its major compound inhibit S100b-induced TGF-Β1 and fibronectin expression in mouse glomerular mesangial cells

European Journal of Pharmacology

Volumn 641, Issue 1, 2010, Pages 7-14

  Jung, Dong Ho ^a   Kim, Young Sook ^a   Kim, Nan Hee ^a   Lee, Jun ^a   Jang, Dae Sik ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Advanced glycation end products; Cassiae Semen; Diabetic nephropathy; Fibronectin; Mouse mesangial cells; Transforming growth factor beta (TGF 1)

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CASSIA EXTRACT; CASSIA SEMEN EXTRACT; CASSIASIDE; DNA; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL PRODUCT; PROTEIN S100B; RUBROFUSARIN 6 O BETA D GENTIOBIOSIDE; SMAD2 PROTEIN; SMAD3 PROTEIN; TORALACTONE 9 O BETA D GENTIOBIOSIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; PLANT EXTRACT; PROTEIN S 100; S100B PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA BINDING; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GLOMERULAR MESANGIAL CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MESANGIUM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; ANIMAL; CASSIA; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DIABETES MELLITUS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PLANT SEED;

ANIMALS; CASSIA; CELL LINE; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; FIBRONECTINS; GENE EXPRESSION REGULATION; LIPID PEROXIDATION; MESANGIAL CELLS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTORS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT EXTRACTS; S100 PROTEINS; SEEDS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 77953808713     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.061     Document Type: Article

References (42)

1. Berrou J., Tostivint I., Verrecchia F., Berthier C., Boulanger E., Mauviel A., Marti H.P., Wautier M.P., Wautier J.L., Rondeau E., Hertig A. Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells. Int. J. Mol. Med. 2009, 23:513-520.
2. Brett J., Schmidt A.M., Yan S.D., Zou Y.S., Weidman E., Neeper M., Przysiecki C., Shaw A., Migheli A., Stern D. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 1993, 143:1699-1712.
3. Cho S.H., Kim T.H., Lee N.H., Son H.S., Cho I.J., Ha T.Y. Effects of Cassia tora fiber supplement on serum lipids in Korean diabetic patients. J. Med. Food 2005, 8:311-318.
4. Choi J.S., Lee H.J., Park K.Y., Jung G.O., Kang S.S. In vitro antimutagenic effects of naphthopyrone glycosides from Cassia tora. Planta Med. 1998, 64:100-104.
5. Figarola J.L., Scott S., Loera S., Tessler C., Chu P., Weiss L., Hardy J., Rahbar S. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia 2003, 46:1140-1152.
6. Figarola J.L., Loera S., Weng Y., Shanmugam N., Natarajan R., Rahbar S. LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia 2008, 51:882-891.
7. Grande J.P. Role of transforming growth factor-beta in tissue injury and repair. Proc. Soc. Exp. Biol. Med. 1997, 214:27-40.
8. Guan Y., Zhao S. Yishou jiangzhi (de-blood-lipid) tablets in the treatment of hyperlipemia. J. Tradit. Chin. 4Med. 1995, 15:178-179.
9. Han D.C., Hoffman B.B., Hong S.W., Guo J., Ziyadeh F.N. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am. J. Physiol. Ren. Physiol. 2000, 278:F628-F634.
10. Han J.-S., Choi B.-S., Yang C.-W., Kim Y.-S. Aldosterone-induced TGF-beta1 expression is regulated by mitogen-activated protein kinase and activator protein-1 in mesangial cells. J. Korean Med. Sci. 2009, 24:S195-S203.
11. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone M.A., Wrana J., Falb D. The MAD related protein Smad7 associates with the TGF-Β receptor and functions as an antagonist of TGF-Β. Cell 1997, 89:1165-1173.
12. Hayashida T., Poncelet A.C., Hubenhak S.C., Schnaper H.W. TGF-Β1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int. 1999, 56:1710-1720.
13. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
14. Hori O., Yan S.D., Ogawa S., Kuwabara K., Matsumoto M., Stern D., Schmidt A.M. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation endproducts on the development of vascular disease in diabetes mellitus. Nephrol. Dial. Transplant. 1996, 11:13-16.
15. Huang Y., Noble N.A., Zhang J., Xu C., Border W.A. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 2007, 72:45-52.
16. Jang D.S., Lee G.Y., Kim Y.S., Lee Y.M., Kim C.S., Yoo J.L., Kim J.S. Anthraquinones from the seeds of Cassia tora with inhibitory activity on protein glycation and aldose reductase. Biol. Pharm. Bull. 2007, 30:2207-2210.
17. Jung D.H., Kim Y.S., Kim J.S. KIOM-79 prevents S100b-induced TGF-beta1 and fironectin expression in mouse mesengial cells. J. Ethnopharmacol. 2009, 125:374-379.
18. Kato M., Yuan H., Xu Z.G., Lanting L., Li S.L., Wang M., Hu M.C., Reddy M.A., Natarajan R. Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J. Am. Soc. Nephrol. 2006, 17:3325-6635.
19. Kim Y.S., Kim B.C., Song C.Y., Hong H.K., Moon K.C., Lee H.S. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta. J. Lab. Clin. Med. 2001, 138:59-68.
20. Kim Y.M., Lee C.H., Kim H.G., Lee H.S. Anthraquinones isolated from Cassia tora (Leguminosae) seed show an antifungal property against phytopathogenic fungi. J. Agric. Food Chem. 2004, 52:6096-6100.
21. Kim Y.S., Jung D.H., Kim N.H., Lee Y.M., Kim J.S. Effect of magnolol on TGF- Β1 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions. Eur. J. Pharmacol. 2007, 562:12-19.
22. Kim Y.S., Kim N.H., Jung D.H., Jang D.S., Lee Y.M., Kim J.M., Kim J.S. Genistein inhibits aldose reductase activity and high glucose-induced TGF-beta2 expression in human lens epithelial cells. Eur. J. Pharmacol. 2008, 594:18-25.
23. Kim Y.S., Kim J., Kim C.S., Sohn E.J., Lee Y.M., Jeong I.H., Kim H., Jang D.S., Kim J.S. KIOM-79, an Inhibitor of AGEs-Protein Cross-linking, Prevents Progression of Nephropathy in Zucker Diabetic Fatty Rats. Evid. Based Complement. Altern. Med. 2009, Jul 15 (Electronic publication ahead of print).
24. Lee G.Y., Jang D.S., Lee Y.M., Kim J.M., Kim J.S. Naphthopyrone Glucosides from the Seeds of Cassia tora with Inhibitory Activity on Advanced Glycation End Products (AGEs) Formation. Arch. Pharm. Res. 2006, 29:587-590.
25. Marles R.J., Farnsworth N.R. Antidiabetic plants and their active constituents. Phytomedicine 1995, 2:137-189.
26. Massague J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 2000, 14:627-644.
27. Ohga S., Shikata K., Yozai K., Okada D., Usui H., Wada J., Shikata Y., Makino H. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. Am. J. Physiol. Ren. Physiol. 2007, 292:F1141-F1150.
28. Oldfield M.D., Bach L.A., Forbes J.M., Paterson D.N., McRobert A., Thallas V., Atkins R.C., Osicka T., Jerums G., Cooper M.E. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J. Clin. Investig. 2001, 108:1853-1863.
29. Poncelet A.C., Schnaper H.W. Regulation of human mesangial cell collagen expression by transforming growth factor-beta1. Am. J. Physiol. 1998, 275:F458-F466.
30. Raptis A.E., Viberti G. Pathogenesis of diabetic nephropathy. Exp. Clin. Endocrinol. Diabetes. 2001, 109:S424-S437.
31. Roberts A.B., Mccune B.K., Sporn M.B. TGF-beta: regulation of extracellular matrix. Kidney Int. 1992, 41:557-559.
32. Ryu M.J., Lee M.Y., Yun S.P., Han H.J. High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-beta1 expression via Ca2+/PKC/MAPKs and PI3Ks/Akt/mTOR signal pathyways. J. Cell. Physiol. 2010, 224:59-70.
33. Sharma K., Ziyadeh F.N. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995, 44:1139-1146.
34. Sharma K., Jin Y., Guo J., Ziyadeh F.N. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996, 45:522-530.
35. Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab. Investig. 1994, 70:138-151.
36. Wolf G. Newinsights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur. J. Clin. Investig. 2004, 34:785-796.
37. Wong S.M., Wong M.M., Seligmann O., Wagner H. Anthraquinone glycosides from the seeds of Cassia tora. Phytochemistry 1989, 28:211-214.
38. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 1994, 269:9889-9897.
39. Yang C.W., Vlassara H., Peten E.P., He C.J., Striker G.E., Striker L.J. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc. Natl. Acad. Sci. U S A. 1994, 91:9436-9440.
40. Zhang Z., Yu B. Total synthesis of the antiallergic naphtho-α-pyrone tetraglucoside, cassiaside C2, isolated from Cassia seeds. J. Org. Chem. 2003, 68:6309-6313.
41. Zimmerman C.M., Padgett R.W. Transforming growth factor B signaling mediators and regulators. Gene 2000, 249:17-30.
42. Ziyadeh F.N., Hoffman B.B., Han D.C., Iglesias-De L., Cruz M.C., Hong S.W., Isono M., Chen S., McGowan T.A., Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth factor-beta antibody in db/db diabetic mice. Proc. Natl Acad. Sci. USA 2000, 97:8015-8020.